US firm offers CRISPR viral knock-out library for R&D
Genomics services company Cellecta is offering gene-editing tool CRISPR to researchers wanting to “knock out” human gene functions.
Genomics services company Cellecta is offering gene-editing tool CRISPR to researchers wanting to “knock out” human gene functions.
Contract research organization INC Research reported 14.2% net service revenue growth in Q2, compared to the same quarter last year, raised future guidance and saw its stock bump up more than 10%.
Contract research organization Charles River Laboratories has extended its initial three-year strategic partnership with AstraZeneca for an additional five years.